{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:07Z","timestamp":1772165587077,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"EU Horizon 2020 MAESTRIA","award":["965286"],"award-info":[{"award-number":["965286"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Arrhythmogenic right ventricular cardiomyopathy (ARVC) or arrhythmogenic cardiomyopathy is a rare inherited disease with incomplete penetrance and an environmental component. Although a rare disease, ARVC is a common cause of sudden cardiac death in young adults. Data on the different stages of ARVC remains scarce. The purpose of this study is to describe the initial presentation and cardiac phenotype of definite and non-definite ARVC for patients seen at a tertiary service.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a single centre, observational cohort study of patients with definite and non-definite ARVC seen at the Inherited Cardiac Conditions services at University Hospital Birmingham (UHB) in the period 2010\u20132021. Patients were identified by interrogation of digital health records, medical history, imaging and by examining 12-lead electrocardiograms (ECG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      The records of 1451 patients were reviewed; of those, 165 patients were at risk of ARVC (mean age 41\u2009\u00b1\u200917\u00a0years, 56% male). 60 patients fulfilled task force criteria for definite ARVC diagnosis (n\u2009=\u200940, 67% males), and 38 (72%) of them carried a known pathogenic variant. The remaining 105 patients (50% males) were non-definite, and of these 45 (62%) carried a known pathogenic variant. Patients in the definite group were more symptomatic, with palpitations (57% vs. 17%), syncope (35% vs. 6%) and shortness of breath (28% vs. 5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). T-wave inversion in V1-V3 and epsilon waves were observed only in the definite group. Both PR interval and QRS duration were longer in the definite (170\u2009\u00b1\u200934\u00a0ms and 100\u2009\u00b1\u200919\u00a0ms,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) compared to (149\u2009\u00b1\u200925 and 91\u2009\u00b1\u200914\u00a0ms,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005). Patients with definite ARVC had significantly larger RV end diastolic areas and significantly reduced biventricular function (RVEDA\u2009=\u200927\u2009\u00b1\u200910\u00a0cm\n                      <jats:sup>2<\/jats:sup>\n                      , RVFAC\u2009=\u200937\u2009\u00b1\u200911% and EF\u2009=\u200956\u2009\u00b1\u200912%) compared to the non-definite group (RVEDA\u2009=\u200918\u2009\u00b1\u20094 cm\n                      <jats:sup>2<\/jats:sup>\n                      , RVFAC 49\u2009\u00b1\u20096% and LVEF 64\u2009\u00b1\u20097%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Sustained ventricular tachycardia (VT) occurred more frequently in the definite group compared to the non-definite group (27% vs. 2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Ventricular fibrillation was observed in the definite group only (8 of 60 patients, 13%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study showed differences between definite and non-definite ARVC patients in terms of clinical, electrophysiological and imaging features. Major adverse cardiac events occurred more commonly in the definite group, but also were observed in non-definite ARVC. This single centre observational cohort study forms a basis for further prospective multicentre interventional studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-022-03021-w","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T12:03:41Z","timestamp":1673525021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Characterisation of patients referred to a tertiary-level inherited cardiac condition clinic with suspected arrhythmogenic right ventricular cardiomyopathy (ARVC)"],"prefix":"10.1186","volume":"23","author":[{"given":"A.","family":"Aljehani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Baig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. C.","family":"Sommerfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ensam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. P.","family":"Steeds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Fabritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"3021_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-020-00702-3","author":"T Zghaib","year":"2021","unstructured":"Zghaib T, Te Riele ASJM, James CA, Rastegar N, Murray B, Tichnell C, et al. Left ventricular fibro-fatty replacement in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: prevalence, patterns, and association with arrhythmias. J Cardiovasc Magn Reson. 2021. https:\/\/doi.org\/10.1186\/s12968-020-00702-3.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"3021_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1161\/CIRCEP.120.008509","volume":"14","author":"J Cadrin-Tourigny","year":"2021","unstructured":"Cadrin-Tourigny J, Bosman LP, Wang W, Tadros R, Bhonsale A, Bourfiss M, et al. Sudden cardiac death prediction in arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythmia Electrophysiol. 2021;14(1):30\u201340. https:\/\/doi.org\/10.1161\/CIRCEP.120.008509.","journal-title":"Circ Arrhythmia Electrophysiol."},{"issue":"1","key":"3021_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.15420\/aer.2020.39","volume":"10","author":"R Wallace","year":"2021","unstructured":"Wallace R, Calkins H. Risk stratification in arrhythmogenic right ventricular cardiomyopathy. Arrhythmia Electrophysiol Rev. 2021;10(1):26\u201332.","journal-title":"Arrhythmia Electrophysiol Rev"},{"key":"3021_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.635141\/full","author":"MP Leone","year":"2021","unstructured":"Leone MP, Palumbo P, Saenen J, Mastroianno S, Castellana S, Amico C, et al. Phenotypic variability of a pathogenic PKP2 mutation in an Italian family affected by arrhythmogenic cardiomyopathy and juvenile sudden death: considerations from molecular autopsy to sport restriction. Front Cardiovasc Med. 2021. https:\/\/doi.org\/10.3389\/fcvm.2021.635141\/full.","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"3021_CR5","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/ejhf.1534","volume":"21","author":"PM Elliott","year":"2019","unstructured":"Elliott PM, Anastasakis A, Asimaki A, Basso C, Bauce B, Brooke MA, et al. Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report. Eur J Heart Fail. 2019;21(8):955\u201364. https:\/\/doi.org\/10.1002\/ejhf.1534.","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"3021_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCGEN.119.002467","volume":"12","author":"FHM van Lint","year":"2019","unstructured":"van Lint FHM, Murray B, Tichnell C, Zwart R, Amat N, Lekanne Deprez RH, et al. Arrhythmogenic right ventricular cardiomyopathy-associated desmosomal variants are rarely De Novo. Circ Genomic Precis Med. 2019;12(8):337\u201344. https:\/\/doi.org\/10.1161\/CIRCGEN.119.002467.","journal-title":"Circ Genomic Precis Med"},{"issue":"1","key":"3021_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1542-474X.1999.tb00372.x","volume":"4","author":"FI Marcus","year":"1999","unstructured":"Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, et al. Right ventricular dysplasia: a report of 24 adult cases. Ann Noninvasive Electrocardiol. 1999;4(1):97\u2013111. https:\/\/doi.org\/10.1111\/j.1542-474X.1999.tb00372.x.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"13","key":"3021_CR8","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","volume":"121","author":"FI Marcus","year":"2010","unstructured":"Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia. Circulation. 2010;121(13):1533\u201341. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.840827.","journal-title":"Circulation"},{"issue":"7","key":"3021_CR9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jacc.2018.05.065","volume":"72","author":"E Gandjbakhch","year":"2018","unstructured":"Gandjbakhch E, Redheuil A, Pousset F, Charron P, Frank R. Clinical diagnosis, imaging, and genetics of arrhythmogenic right ventricular cardiomyopathy\/dysplasia. J Am Coll Cardiol. 2018;72(7):784\u2013804.","journal-title":"J Am Coll Cardiol"},{"issue":"41","key":"3021_CR10","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Bloma N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the Europea. Eur Heart J. 2015;36(41):2793\u20132867l.","journal-title":"Eur Heart J"},{"issue":"22","key":"3021_CR11","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1161\/01.CIR.0000128363.85581.E1","volume":"109","author":"BJ Maron","year":"2004","unstructured":"Maron BJ, Chaitman BR, Ackerman MJ, Bay\u00e9s de Luna A, Corrado D, Crosson JE, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109(22):2807\u201316. https:\/\/doi.org\/10.1161\/01.CIR.0000128363.85581.E1.","journal-title":"Circulation"},{"issue":"4","key":"3021_CR12","doi-asserted-by":"publisher","first-page":"G59","DOI":"10.1530\/ERP-20-0026","volume":"7","author":"S Robinson","year":"2020","unstructured":"Robinson S, Rana B, Oxborough D, Steeds R, Monaghan M, Stout M, et al. A practical guideline for performing a comprehensive transthoracic echocardiogram in adults: the British society of echocardiography minimum dataset. Echo Res Pract. 2020;7(4):G59-93. https:\/\/doi.org\/10.1530\/ERP-20-0026.","journal-title":"Echo Res Pract"},{"issue":"1","key":"3021_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1532-429X-15-91","volume":"15","author":"CM Kramer","year":"2013","unstructured":"Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013;15(1):91. https:\/\/doi.org\/10.1186\/1532-429X-15-91.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"23","key":"3021_CR14","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1161\/CIRCULATIONAHA.110.988287","volume":"123","author":"MGPJ Cox","year":"2011","unstructured":"Cox MGPJ, Van Der Zwaag PA, Van Der Werf C, Van Der Smagt JJ, Noorman M, Bhuiyan ZA, et al. Arrhythmogenic right ventricular dysplasia\/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia\/cardiomyopathy genotype-phenotype follow-up study. Circulation. 2011;123(23):2690\u2013700.","journal-title":"Circulation"},{"issue":"19","key":"3021_CR15","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/eurheartj\/ehx011","volume":"38","author":"D Akdis","year":"2017","unstructured":"Akdis D, Saguner AM, Shah K, Wei C, Medeiros-Domingo A, Von Eckardstein A, et al. Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy\/dysplasia: Froma stemcell derived cardiomyocyte-based model to clinical biomarkers of disease outcome. Eur Heart J. 2017;38(19):1498\u2013508.","journal-title":"Eur Heart J"},{"issue":"14","key":"3021_CR16","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","volume":"62","author":"CA James","year":"2013","unstructured":"James CA, Bhonsale A, Tichnell C, Murray B, Russell SD, Tandri H, et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy\u2013associated desmosomal mutation carriers. J Am Coll Cardiol. 2013;62(14):1290\u20137.","journal-title":"J Am Coll Cardiol."},{"issue":"8","key":"3021_CR17","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.hrthm.2020.03.007","volume":"17","author":"A Gasperetti","year":"2020","unstructured":"Gasperetti A, Dello Russo A, Busana M, Dessanai M, Pizzamiglio F, Saguner AM, et al. Novel risk calculator performance in athletes with arrhythmogenic right ventricular cardiomyopathy. Hear Rhythm. 2020;17(8):1251\u20139. https:\/\/doi.org\/10.1016\/j.hrthm.2020.03.007.","journal-title":"Hear Rhythm"},{"issue":"8","key":"3021_CR18","doi-asserted-by":"publisher","first-page":"628.e9","DOI":"10.1016\/j.crad.2021.04.002","volume":"76","author":"Y Liu","year":"2021","unstructured":"Liu Y, Yu J, Liu J, Wu B, Cui Q, Shen W, et al. Prognostic value of late gadolinium enhancement in arrhythmogenic right ventricular cardiomyopathy: a meta-analysis. Clin Radiol. 2021;76(8):628.e9-628.e15.","journal-title":"Clin Radiol"},{"issue":"19","key":"3021_CR19","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jacc.2013.01.073","volume":"61","author":"FI Marcus","year":"2013","unstructured":"Marcus FI, Edson S, Towbin JA. Genetics of arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2013;61(19):1945\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2013.01.073.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"3021_CR20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/eurheartj\/ehr069","volume":"32","author":"SI Sarvari","year":"2011","unstructured":"Sarvari SI, Haugaa KH, Anfinsen O-G, Leren TP, Smiseth OA, Kongsgaard E, et al. Right ventricular mechanical dispersion is related to malignant arrhythmias: a study of patients with arrhythmogenic right ventricular cardiomyopathy and subclinical right ventricular dysfunction. Eur Heart J. 2011;32(9):1089\u201396. https:\/\/doi.org\/10.1093\/eurheartj\/ehr069.","journal-title":"Eur Heart J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-03021-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-03021-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-03021-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T12:05:51Z","timestamp":1673525151000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-03021-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3021"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-03021-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1804660\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"assertion":[{"value":"28 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were approved by the local clinical governance committee (audit number: Clinical Audit Registration and Management system by Birmingham\u2019s Children\u2019s Hospital Clinical Audit and Effectiveness Lead\/University Hospital\u2019s Birmingham, ((CARMS)-16044, 17734) and conformed to the Good Clinical Practice guidelines. The local clinical governance committee has the authority to approve and waive the ethical approval and informed consent. All methods were performed in accordance with the relevant guidelines and regulations. As this observational study was performed as part of an audit ((CARMS)-16044, 17734) in patients receiving standard NHS care, the clinical audit committee by Birmingham\u2019s Children\u2019s Hospital Clinical Audit and Effectiveness Lead\/University Hospital\u2019s Birmingham thereby waived the need of informed consent. From 2020, patients have given Human Biomaterial Resource Centre (HBRC), a Human Tissue Authority (HTA) licensed human sample biorepository operated by the University of Birmingham informed consent to provide blood samples and clinical data (study title: Heartbeat Matrix Pilot: Accelerating targeted treatments for patients with inherited heart diseases. REC reference: 20\/LO\/0184 IRAS project ID: 269251, REC name: London\u2014West London & GTAC Research Ethics Committee).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests to the work in this submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}